Evidence map›Paper›PMID 35051349›Full record

ArticleCell host & microbe2022

Establishment and characterization of stable, diverse, fecal-derived in vitro microbial communities that model the intestinal microbiota.

Andrés Aranda-Díaz, Katharine Michelle Ng, Tani Thomsen, Imperio Real-Ramírez, Dylan Dahan, Susannah Dittmar, Carlos Gutierrez Gonzalez, Taylor Chavez, Kimberly S Vasquez, Taylor H Nguyen and 6 more

Open access · greenAbstract read
In one paragraph

Article in Cell host & microbe, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 120 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Multi-region sampling of the human small intestine using an ingestible device.medRxiv : the preprint server for health sciences · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Gut microbes · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Andrés Aranda-DíazDepartment of Bioengineering, Stanford University, Stanford, CA 94305, USA.
Katharine Michelle NgDepartment of Bioengineering, Stanford University, Stanford, CA 94305, USA.
Tani ThomsenDepartment of Bioengineering, Stanford University, Stanford, CA 94305, USA.
Imperio Real-RamírezDepartment of Bioengineering, Stanford University, Stanford, CA 94305, USA.
Dylan DahanDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Susannah DittmarDepartment of Bioengineering, Stanford University, Stanford, CA 94305, USA.
Carlos Gutierrez GonzalezDepartment of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Taylor ChavezDepartment of Bioengineering, Stanford University, Stanford, CA 94305, USA.
Kimberly S VasquezDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Taylor H NguyenDepartment of Bioengineering, Stanford University, Stanford, CA 94305, USA.
Feiqiao Brian YuChan Zuckerberg Biohub, San Francisco, CA 94158, USA.
Steven K HigginbottomDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Norma F NeffChan Zuckerberg Biohub, San Francisco, CA 94158, USA.
Joshua E EliasChan Zuckerberg Biohub, San Francisco, CA 94158, USA.
Justin L SonnenburgDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA; Chan Zuckerberg Biohub, San Francisco, CA 94158, USA.
Kerwyn Casey HuangDepartment of Bioengineering, Stanford University, Stanford, CA 94305, USA; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA; Chan Zuckerberg Biohub, San Francisco, CA 94158, USA. Electronic address: kchuang@stanford.edu.
Stanford University · USChan Zuckerberg Initiative (United States) · US

Funding

A universal pipeline for functional characterization of the human microbiota at a massive scaleRM1GM135102 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BUIE, CULLEN RICHARD, DEUTSCHBAUER, ADAM M · 2020 to 2024
$7.6M
Impact of Diet on Intestinal Microbiota-Host DynamicsR01DK085025 · NIDDK · STANFORD UNIVERSITY · PI JUSTIN L SONNENBURG · 2010 to 2026
$6.4M
Molecular Biophysics Training Program at StanfordT32GM136568 · NIGMS · STANFORD UNIVERSITY · PI Zev Bryant, KERWYN C. HUANG · 2021 to 2026
$3.7M
NIDDK NIH HHS R01 DK085025NIGMS NIH HHS RM1 GM135102
6 · The paper itself

Abstract

Efforts to probe the role of the gut microbiota in disease would benefit from a system in which patient-derived bacterial communities can be studied at scale. We addressed this by validating a strategy to propagate phylogenetically complex, diverse, stable, and highly reproducible stool-derived communities in vitro. We generated hundreds of in vitro communities cultured from diverse stool samples in various media; certain media generally preserved inoculum composition, and inocula from different subjects yielded source-specific community compositions. Upon colonization of germ-free mice, community composition was maintained, and the host proteome resembled the host from which the community was derived. Treatment with ciprofloxacin in vivo increased susceptibility to Salmonella invasion in vitro, and the in vitro response to ciprofloxacin was predictive of compositional changes observed in vivo, including the resilience and sensitivity of each Bacteroides species. These findings demonstrate that stool-derived in vitro communities can serve as a powerful system for microbiota research.

Indexed as

Gastrointestinal MicrobiomeMicrobiotaAnimalsBacteriaBacteroidesFecesHumansMiceantibioticsciprofloxacinculturomicsecological stabilityex vivogut microbiotamicrobial ecologymicrobiota perturbationssynthetic communities

Identifiers

PMID35051349
PMCPMC9082339
OpenAlexW4205952448

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.